I think focusing their advertising dollars in foreign markets and developing countries is a logical step for pharmaceutical companies, who are being vilified Stateside.
Having been exiled in the US, drug reps thrive overseas
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
More in Uncategorized
Past Week
-
What’s driving medical students away from primary care?
-
Make cognitive testing as routine as a blood pressure check
-
A faster path to becoming a doctor is possible—here’s how
-
A world without antidepressants: What could possibly go wrong?
-
Conflicts of interest are eroding trust in U.S. health agencies
-
Precision and personalization: Charting the future of cancer care [PODCAST]
-
Past 6 Months
-
What’s driving medical students away from primary care?
-
Internal Medicine 2025: inspiration at the annual meeting
-
The silent crisis hurting pain patients and their doctors
-
What happened to real care in health care?
-
Are quotas a solution to physician shortages?
-
The hidden bias in how we treat chronic pain
-
Recent Posts
-
Precision and personalization: Charting the future of cancer care [PODCAST]
-
Expert Q&A: Dr. Jared Pelo, ambient clinical pioneer, explains how Dragon Copilot helps clinicians deliver better care
-
The lab behind the lens: Equity begins with diagnosis
-
Venous leak syndrome: a silent challenge faced by all men
-
Rethinking patient payments: Why billing is the new frontline of patient care [PODCAST]
-
The dreaded question: Do you have boys or girls?
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
